International Business Machines Corp. (IBM) received a thumbs-up from Wedbush analysts on Wednesday after its strong ...

Wedbush Securities, a leading financial services and investment firm, is proud to announce the launch of fast and efficient services for easy-to-borrow, locates and hard-to-borrow securities. This ...

Wedbush analyst Seth Basham upgraded Tempur Sealy (TPX) to Outperform from Neutral with a price target of $80, up from $67. On Friday night, ...

Healthcare Realty Trust Inc (HR) stock saw a decline, ending the day at $16.41 which represents a decrease of $-0.14 or -0.85% from the prior close of $16.55. The stock opened at $16.46 and touched a ...

Equities research analysts at Wedbush dropped their Q3 2025 earnings per share estimates for shares of Tesla in a research ...

Wedbush's Dan Ives believes buying Palantir Technologies Inc (NYSE:PLTR) stock right now could be like buying Tesla Inc ...

Equities research analysts at Wedbush boosted their FY2024 EPS estimates for shares of Zentalis Pharmaceuticals in a research note issued to investors on Wednesday, January 29th. Wedbush analyst R.

Wedbush analyst Daniel Ives assumed coverage of CI&T with an Outperform rating and $9 price target Overall, the firm remains bullish as it ...

Dan Ives, Wedbush Securities global head of technology research, joins 'Squawk on the Street' to discuss Ives' biggest ...

For Elon Musk fans, it’s the half-trillion dollar bet. The stock market value of Tesla has surged by that much since Donald ...

Wedbush analyst Matt Bryson lowered the firm’s price target on Intel (INTC) to $20 from $25 and keeps a Neutral rating on the ...

Palantir Technologies shares soared to an all-time high Tuesday after the company's outlook blew past analysts' expectations on strong demand for AI.